 | • レポートコード：D0GIR-12453 • 出版社/出版日：GlobalInfoResearch / 2020年9月30日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、101ページ • 納品方法：Eメール • 産業分類：医療、製薬、バイオ |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、レンデシビル（新型コロナ）の世界市場を広く調査・分析し、今後の市場展望をまとめております。レンデシビル（新型コロナ）の種類別市場規模（5mg、10mg、50mg、100mg）、用途別市場規模（病院、クリニック、ドラッグストア、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、メーカー別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・市場概要 ・メーカー情報（販売量、市場シェア、製品概要、SWOT分析）：Gilead Sciences、Inovio Pharmaceuticals、Kelun Pharma、Bright Gene、Berry Global Group、Hainan Haiyao、Borui Bio-Pharmaceutical、Hunan Warrant Pharmaceutical ・地域別グローバル市場分析 2015年-2020年 ・レンデシビル（新型コロナ）の北米市場（アメリカ、カナダ、メキシコ） ・レンデシビル（新型コロナ）のヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・レンデシビル（新型コロナ）のアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・レンデシビル（新型コロナ）の南米市場（ブラジル、アルゼンチン） ・レンデシビル（新型コロナ）の中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：5mg、10mg、50mg、100mg ・用途別分析：病院、クリニック、ドラッグストア、その他 ・地域別市場規模予測 2021年-2025年 ・販売チャネル、流通業者、代理店 ・調査の結果・結論 |
Market Overview
The Remdesivir (COVID-19) market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
The most likely (base case) scenario is that the global Remdesivir (COVID-19) sales will be xx in 2020 from Remdesivir (COVID-19) million in 2019, with a change xx% between 2019 and 2020. In addition, based on the latest study, it is to predict that the Covid-19 will be under control in key countries like the United States, Western Europe, East Asia, by the end of Q2 (June), and will resume normal production in Q3 and Q4, the global Remdesivir (COVID-19) market size is expected to grow at xx% or more annually for the next five years.
This report also researches and evaluates the impact of Covid-19 outbreak on the Remdesivir (COVID-19) industry, involving potential opportunity and challenges, drivers and risks. We present the impact assessment of Covid-19 effects on Remdesivir (COVID-19) and market growth forecast based on different scenario (optimistic, pessimistic, very optimistic, most likely etc.).
Market segmentation
Remdesivir (COVID-19) market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Remdesivir (COVID-19) market has been segmented into
5mg
10mg
50mg
100mg
By Application, Remdesivir (COVID-19) has been segmented into:
Hospital
Clinics
Drug Store
Others
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Remdesivir (COVID-19) market presented in the report. This section sheds light on the sales growth of different regional and country-level Remdesivir (COVID-19) markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Remdesivir (COVID-19) market.
The report offers in-depth assessment of the growth and other aspects of the Remdesivir (COVID-19) market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, etc.)
Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)
Competitive Landscape and Remdesivir (COVID-19) Market Share Analysis
Remdesivir (COVID-19) competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Remdesivir (COVID-19) sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Remdesivir (COVID-19) sales, revenue and market share for each player covered in this report.
The major players covered in Remdesivir (COVID-19) are:
Gilead Sciences
Inovio Pharmaceuticals
Kelun Pharma
Bright Gene
Berry Global Group
Hainan Haiyao
Borui Bio-Pharmaceutical
Hunan Warrant Pharmaceutical
Among other players domestic and global, Remdesivir (COVID-19) market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Remdesivir (COVID-19) product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Remdesivir (COVID-19), with price, sales, revenue and global market share of Remdesivir (COVID-19) in 2018 and 2019.
Chapter 3, the Remdesivir (COVID-19) competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Remdesivir (COVID-19) breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, Remdesivir (COVID-19) market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe Remdesivir (COVID-19) sales channel, distributors, customers, research findings and conclusion, appendix and data source.
1 Market Overview
1.1 Remdesivir (COVID-19) Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Remdesivir (COVID-19) Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 5mg
1.2.3 10mg
1.2.4 50mg
1.2.5 100mg
1.3 Market Analysis by Application
1.3.1 Overview: Global Remdesivir (COVID-19) Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Hospital
1.3.3 Clinics
1.3.4 Drug Store
1.3.5 Others
1.4 Overview of Global Remdesivir (COVID-19) Market
1.4.1 Global Remdesivir (COVID-19) Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
1.6 COVID-19 Outbreak: Remdesivir (COVID-19) Industry Impact
1.6.1 COVID-19 Potential Implications for the Remdesivir (COVID-19)
1.6.1.1 Scenario One: Very Optimistic: COVID-19 has No Influence on Remdesivir (COVID-19)
1.6.1.2 Scenario Two: Optimistic: COVID-19 Will Be Under Control by the End of April
1.6.1.3 Scenario Three: Gloomy: COVID-19 Will Be Under Control Between Q3 and Q4
1.6.1.4 Scenario Four: Most Likely: COVID-19 Will Be Under Control by the End of Q2
1.6.2 Opportunity Analysis in Covid-19 Crisis
1.6.3 Market Risk and Restraints
1.6.4 Market Driving Force
2 Manufacturers Profiles
2.1 Gilead Sciences
2.1.1 Gilead Sciences Details
2.1.2 Gilead Sciences Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Gilead Sciences SWOT Analysis
2.1.4 Gilead Sciences Product and Services
2.1.5 Gilead Sciences Remdesivir (COVID-19) Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 Inovio Pharmaceuticals
2.2.1 Inovio Pharmaceuticals Details
2.2.2 Inovio Pharmaceuticals Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Inovio Pharmaceuticals SWOT Analysis
2.2.4 Inovio Pharmaceuticals Product and Services
2.2.5 Inovio Pharmaceuticals Remdesivir (COVID-19) Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 Kelun Pharma
2.3.1 Kelun Pharma Details
2.3.2 Kelun Pharma Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Kelun Pharma SWOT Analysis
2.3.4 Kelun Pharma Product and Services
2.3.5 Kelun Pharma Remdesivir (COVID-19) Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 Bright Gene
2.4.1 Bright Gene Details
2.4.2 Bright Gene Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Bright Gene SWOT Analysis
2.4.4 Bright Gene Product and Services
2.4.5 Bright Gene Remdesivir (COVID-19) Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.5 Berry Global Group
2.5.1 Berry Global Group Details
2.5.2 Berry Global Group Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Berry Global Group SWOT Analysis
2.5.4 Berry Global Group Product and Services
2.5.5 Berry Global Group Remdesivir (COVID-19) Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.6 Hainan Haiyao
2.6.1 Hainan Haiyao Details
2.6.2 Hainan Haiyao Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Hainan Haiyao SWOT Analysis
2.6.4 Hainan Haiyao Product and Services
2.6.5 Hainan Haiyao Remdesivir (COVID-19) Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.7 Borui Bio-Pharmaceutical
2.7.1 Borui Bio-Pharmaceutical Details
2.7.2 Borui Bio-Pharmaceutical Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Borui Bio-Pharmaceutical SWOT Analysis
2.7.4 Borui Bio-Pharmaceutical Product and Services
2.7.5 Borui Bio-Pharmaceutical Remdesivir (COVID-19) Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.8 Hunan Warrant Pharmaceutical
2.8.1 Hunan Warrant Pharmaceutical Details
2.8.2 Hunan Warrant Pharmaceutical Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Hunan Warrant Pharmaceutical SWOT Analysis
2.8.4 Hunan Warrant Pharmaceutical Product and Services
2.8.5 Hunan Warrant Pharmaceutical Remdesivir (COVID-19) Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global Remdesivir (COVID-19) Sales and Market Share by Manufacturer (2018-2019)
3.2 Global Remdesivir (COVID-19) Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Remdesivir (COVID-19) Manufacturer Market Share in 2019
3.3.2 Top 6 Remdesivir (COVID-19) Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global Remdesivir (COVID-19) Sales, Revenue and Market Share by Regions
4.1.1 Global Remdesivir (COVID-19) Sales and Market Share by Regions (2015-2020)
4.1.2 Global Remdesivir (COVID-19) Revenue and Market Share by Regions (2015-2020)
4.2 North America Remdesivir (COVID-19) Sales and Growth Rate (2015-2020)
4.3 Europe Remdesivir (COVID-19) Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific Remdesivir (COVID-19) Sales and Growth Rate (2015-2020)
4.5 South America Remdesivir (COVID-19) Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa Remdesivir (COVID-19) Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America Remdesivir (COVID-19) Sales, Revenue and Market Share by Country
5.1.1 North America Remdesivir (COVID-19) Sales and Market Share by Country (2015-2020)
5.1.2 North America Remdesivir (COVID-19) Revenue and Market Share by Country (2015-2020)
5.2 United States Remdesivir (COVID-19) Sales and Growth Rate (2015-2020)
5.3 Canada Remdesivir (COVID-19) Sales and Growth Rate (2015-2020)
5.4 Mexico Remdesivir (COVID-19) Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe Remdesivir (COVID-19) Sales, Revenue and Market Share by Country
6.1.1 Europe Remdesivir (COVID-19) Sales and Market Share by Country (2015-2020)
6.1.2 Europe Remdesivir (COVID-19) Revenue and Market Share by Country (2015-2020)
6.2 Germany Remdesivir (COVID-19) Sales and Growth Rate (2015-2020)
6.3 UK Remdesivir (COVID-19) Sales and Growth Rate (2015-2020)
6.4 France Remdesivir (COVID-19) Sales and Growth Rate (2015-2020)
6.5 Russia Remdesivir (COVID-19) Sales and Growth Rate (2015-2020)
6.6 Italy Remdesivir (COVID-19) Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Remdesivir (COVID-19) Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific Remdesivir (COVID-19) Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific Remdesivir (COVID-19) Revenue and Market Share by Regions (2015-2020)
7.2 China Remdesivir (COVID-19) Sales and Growth Rate (2015-2020)
7.3 Japan Remdesivir (COVID-19) Sales and Growth Rate (2015-2020)
7.4 Korea Remdesivir (COVID-19) Sales and Growth Rate (2015-2020)
7.5 India Remdesivir (COVID-19) Sales and Growth Rate (2015-2020)
7.6 Southeast Asia Remdesivir (COVID-19) Sales and Growth Rate (2015-2020)
7.7 Australia Remdesivir (COVID-19) Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America Remdesivir (COVID-19) Sales, Revenue and Market Share by Country
8.1.1 South America Remdesivir (COVID-19) Sales and Market Share by Country (2015-2020)
8.1.2 South America Remdesivir (COVID-19) Revenue and Market Share by Country (2015-2020)
8.2 Brazil Remdesivir (COVID-19) Sales and Growth Rate (2015-2020)
8.3 Argentina Remdesivir (COVID-19) Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Remdesivir (COVID-19) Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa Remdesivir (COVID-19) Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa Remdesivir (COVID-19) Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia Remdesivir (COVID-19) Sales and Growth Rate (2015-2020)
9.3 Turkey Remdesivir (COVID-19) Sales and Growth Rate (2015-2020)
9.4 Egypt Remdesivir (COVID-19) Sales and Growth Rate (2015-2020)
9.5 South Africa Remdesivir (COVID-19) Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global Remdesivir (COVID-19) Sales and Market Share by Type (2015-2020)
10.2 Global Remdesivir (COVID-19) Revenue and Market Share by Type (2015-2020)
10.3 Global Remdesivir (COVID-19) Price by Type (2015-2020)
11 Global Remdesivir (COVID-19) Market Segment by Application
11.1 Global Remdesivir (COVID-19) Sales Market Share by Application (2015-2020)
11.2 Global Remdesivir (COVID-19) Revenue Market Share by Application (2015-2020)
11.3 Global Remdesivir (COVID-19) Price by Application (2015-2020)
12 Market Forecast
12.1 Global Remdesivir (COVID-19) Sales, Revenue and Growth Rate (2021-2025)
12.2 Remdesivir (COVID-19) Market Forecast by Regions (2021-2025)
12.2.1 North America Remdesivir (COVID-19) Market Forecast (2021-2025)
12.2.2 Europe Remdesivir (COVID-19) Market Forecast (2021-2025)
12.2.3 Asia-Pacific Remdesivir (COVID-19) Market Forecast (2021-2025)
12.2.4 South America Remdesivir (COVID-19) Market Forecast (2021-2025)
12.2.5 Middle East & Africa Remdesivir (COVID-19) Market Forecast (2021-2025)
12.3 Remdesivir (COVID-19) Market Forecast by Type (2021-2025)
12.3.1 Global Remdesivir (COVID-19) Sales Forecast by Type (2021-2025)
12.3.2 Global Remdesivir (COVID-19) Market Share Forecast by Type (2021-2025)
12.4 Remdesivir (COVID-19) Market Forecast by Application (2021-2025)
12.4.1 Global Remdesivir (COVID-19) Sales Forecast by Application (2021-2025)
12.4.2 Global Remdesivir (COVID-19) Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US
Table 1. Global Remdesivir (COVID-19) Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Remdesivir (COVID-19) by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Remdesivir (COVID-19) Market Size and Growth Estimation in Various Scenarios in 2020
Table 4. Global Remdesivir (COVID-19) Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 5. Market Opportunities in Next Few Years
Table 6. Market Risks Analysis
Table 7. Market Drivers
Table 8. Gilead Sciences Basic Information, Manufacturing Base and Competitors
Table 9. Gilead Sciences Remdesivir (COVID-19) Major Business
Table 10. Gilead Sciences Remdesivir (COVID-19) Total Revenue (USD Million) (2018-2019)
Table 11. Gilead Sciences SWOT Analysis
Table 12. Gilead Sciences Remdesivir (COVID-19) Product and Services
Table 13. Gilead Sciences Remdesivir (COVID-19) Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 14. Inovio Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 15. Inovio Pharmaceuticals Remdesivir (COVID-19) Major Business
Table 16. Inovio Pharmaceuticals Remdesivir (COVID-19) Total Revenue (USD Million) (2018-2019)
Table 17. Inovio Pharmaceuticals SWOT Analysis
Table 18. Inovio Pharmaceuticals Remdesivir (COVID-19) Product and Services
Table 19. Inovio Pharmaceuticals Remdesivir (COVID-19) Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 20. Kelun Pharma Basic Information, Manufacturing Base and Competitors
Table 21. Kelun Pharma Remdesivir (COVID-19) Major Business
Table 22. Kelun Pharma Remdesivir (COVID-19) Total Revenue (USD Million) (2018-2019)
Table 23. Kelun Pharma SWOT Analysis
Table 24. Kelun Pharma Remdesivir (COVID-19) Product and Services
Table 25. Kelun Pharma Remdesivir (COVID-19) Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 26. Bright Gene Basic Information, Manufacturing Base and Competitors
Table 27. Bright Gene Remdesivir (COVID-19) Major Business
Table 28. Bright Gene Remdesivir (COVID-19) Total Revenue (USD Million) (2018-2019)
Table 29. Bright Gene SWOT Analysis
Table 30. Bright Gene Remdesivir (COVID-19) Product and Services
Table 31. Bright Gene Remdesivir (COVID-19) Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 32. Berry Global Group Basic Information, Manufacturing Base and Competitors
Table 33. Berry Global Group Remdesivir (COVID-19) Major Business
Table 34. Berry Global Group Remdesivir (COVID-19) Total Revenue (USD Million) (2018-2019)
Table 35. Berry Global Group SWOT Analysis
Table 36. Berry Global Group Remdesivir (COVID-19) Product and Services
Table 37. Berry Global Group Remdesivir (COVID-19) Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 38. Hainan Haiyao Basic Information, Manufacturing Base and Competitors
Table 39. Hainan Haiyao Remdesivir (COVID-19) Major Business
Table 40. Hainan Haiyao Remdesivir (COVID-19) Total Revenue (USD Million) (2018-2019)
Table 41. Hainan Haiyao SWOT Analysis
Table 42. Hainan Haiyao Remdesivir (COVID-19) Product and Services
Table 43. Hainan Haiyao Remdesivir (COVID-19) Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 44. Borui Bio-Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 45. Borui Bio-Pharmaceutical Remdesivir (COVID-19) Major Business
Table 46. Borui Bio-Pharmaceutical Remdesivir (COVID-19) Total Revenue (USD Million) (2018-2019)
Table 47. Borui Bio-Pharmaceutical SWOT Analysis
Table 48. Borui Bio-Pharmaceutical Remdesivir (COVID-19) Product and Services
Table 49. Borui Bio-Pharmaceutical Remdesivir (COVID-19) Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 50. Hunan Warrant Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 51. Hunan Warrant Pharmaceutical Remdesivir (COVID-19) Major Business
Table 52. Hunan Warrant Pharmaceutical Remdesivir (COVID-19) Total Revenue (USD Million) (2018-2019)
Table 53. Hunan Warrant Pharmaceutical SWOT Analysis
Table 54. Hunan Warrant Pharmaceutical Remdesivir (COVID-19) Product and Services
Table 55. Hunan Warrant Pharmaceutical Remdesivir (COVID-19) Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 56. Global Remdesivir (COVID-19) Sales by Manufacturer (2018-2019) (K Units)
Table 57. Global Remdesivir (COVID-19) Revenue by Manufacturer (2018-2019) (USD Million)
Table 58. Global Remdesivir (COVID-19) Sales by Regions (2015-2020) (K Units)
Table 59. Global Remdesivir (COVID-19) Sales Market Share by Regions (2015-2020)
Table 60. Global Remdesivir (COVID-19) Revenue by Regions (2015-2020) (USD Million)
Table 61. North America Remdesivir (COVID-19) Sales by Countries (2015-2020) (K Units)
Table 62. North America Remdesivir (COVID-19) Sales Market Share by Countries (2015-2020)
Table 63. North America Remdesivir (COVID-19) Revenue by Countries (2015-2020) (USD Million)
Table 64. North America Remdesivir (COVID-19) Revenue Market Share by Countries (2015-2020)
Table 65. Europe Remdesivir (COVID-19) Sales by Countries (2015-2020) (K Units)
Table 66. Europe Remdesivir (COVID-19) Sales Market Share by Countries (2015-2020)
Table 67. Europe Remdesivir (COVID-19) Revenue by Countries (2015-2020) (USD Million)
Table 68. Asia-Pacific Remdesivir (COVID-19) Sales by Regions (2015-2020) (K Units)
Table 69. Asia-Pacific Remdesivir (COVID-19) Sales Market Share by Regions (2015-2020)
Table 70. Asia-Pacific Remdesivir (COVID-19) Revenue by Regions (2015-2020) (USD Million)
Table 71. South America Remdesivir (COVID-19) Sales by Countries (2015-2020) (K Units)
Table 72. South America Remdesivir (COVID-19) Sales Market Share by Countries (2015-2020)
Table 73. South America Remdesivir (COVID-19) Revenue by Countries (2015-2020) (USD Million)
Table 74. South America Remdesivir (COVID-19) Revenue Market Share by Countries (2015-2020)
Table 75. Middle East & Africa Remdesivir (COVID-19) Sales by Countries (2015-2020) (K Units)
Table 76. Middle East & Africa Remdesivir (COVID-19) Sales Market Share by Countries (2015-2020)
Table 77. Middle East & Africa Remdesivir (COVID-19) Revenue by Countries (2015-2020) (USD Million)
Table 78. Middle East & Africa Remdesivir (COVID-19) Revenue Market Share by Countries (2015-2020)
Table 79. Global Remdesivir (COVID-19) Sales by Type (2015-2020) (K Units)
Table 80. Global Remdesivir (COVID-19) Sales Share by Type (2015-2020)
Table 81. Global Remdesivir (COVID-19) Revenue by Type (2015-2020) (USD Million)
Table 82. Global Remdesivir (COVID-19) Revenue Share by Type (2015-2020)
Table 83. Global Remdesivir (COVID-19) Sales by Application (2015-2020) (K Units)
Table 84. Global Remdesivir (COVID-19) Sales Share by Application (2015-2020)
Table 85. Global Remdesivir (COVID-19) Sales Forecast by Regions (2021-2025) (K Units)
Table 86. Global Remdesivir (COVID-19) Market Share Forecast by Regions (2021-2025)
Table 87. Global Remdesivir (COVID-19) Sales Forecast by Type (2021-2025) (K Units)
Table 88. Global Remdesivir (COVID-19) Market Share Forecast by Type (2021-2025)
Table 89. Global Remdesivir (COVID-19) Sales Forecast by Application (2021-2025)
Table 90. Global Remdesivir (COVID-19) Market Share Forecast by Application (2021-2025)
Table 91. Direct Channel Pros & Cons
Table 92. Indirect Channel Pros & Cons
Table 93. Distributors/Traders/ Dealers List
List of Figures
Figure 1. Remdesivir (COVID-19) Picture
Figure 2. Global Sales Market Share of Remdesivir (COVID-19) by Type in 2019
Figure 3. 5mg Picture
Figure 4. 10mg Picture
Figure 5. 50mg Picture
Figure 6. 100mg Picture
Figure 7. Remdesivir (COVID-19) Sales Market Share by Application in 2018
Figure 8. Hospital Picture
Figure 9. Clinics Picture
Figure 10. Drug Store Picture
Figure 11. Others Picture
Figure 12. Global Remdesivir (COVID-19) Market Status and Outlook (2015-2025) (USD Million)
Figure 13. United States Remdesivir (COVID-19) Revenue (Value) and Growth Rate (2015-2025)
Figure 14. Canada Remdesivir (COVID-19) Revenue (Value) and Growth Rate (2015-2025)
Figure 15. Mexico Remdesivir (COVID-19) Revenue (Value) and Growth Rate (2015-2025)
Figure 16. Germany Remdesivir (COVID-19) Revenue (Value) and Growth Rate (2015-2025)
Figure 17. France Remdesivir (COVID-19) Revenue (Value) and Growth Rate (2015-2025)
Figure 18. UK Remdesivir (COVID-19) Revenue (Value) and Growth Rate (2015-2025)
Figure 19. Russia Remdesivir (COVID-19) Revenue (Value) and Growth Rate (2015-2025)
Figure 20. Italy Remdesivir (COVID-19) Revenue (Value) and Growth Rate (2015-2025)
Figure 21. China Remdesivir (COVID-19) Revenue (Value) and Growth Rate (2015-2025)
Figure 22. Japan Remdesivir (COVID-19) Revenue (Value) and Growth Rate (2015-2025)
Figure 23. Korea Remdesivir (COVID-19) Revenue (Value) and Growth Rate (2015-2025)
Figure 24. India Remdesivir (COVID-19) Revenue (Value) and Growth Rate (2015-2025)
Figure 25. Southeast Asia Remdesivir (COVID-19) Revenue (Value) and Growth Rate (2015-2025)
Figure 26. Australia Remdesivir (COVID-19) Revenue (Value) and Growth Rate (2015-2025) (USD Million)
Figure 27. Brazil Remdesivir (COVID-19) Revenue (Value) and Growth Rate (2015-2025)
Figure 28. Egypt Remdesivir (COVID-19) Revenue (Value) and Growth Rate (2015-2025)
Figure 29. Saudi Arabia Remdesivir (COVID-19) Revenue (Value) and Growth Rate (2015-2025)
Figure 30. South Africa Remdesivir (COVID-19) Revenue (Value) and Growth Rate (2015-2025)
Figure 31. Turkey Remdesivir (COVID-19) Revenue (Value) and Growth Rate (2015-2025)
Figure 32. Global Remdesivir (COVID-19) Sales Market Share by Manufacturer in 2019
Figure 33. Global Remdesivir (COVID-19) Revenue Market Share by Manufacturer in 2019
Figure 34. Top 3 Remdesivir (COVID-19) Manufacturer (Revenue) Market Share in 2019
Figure 35. Top 6 Remdesivir (COVID-19) Manufacturer (Revenue) Market Share in 2019
Figure 36. Key Manufacturer Market Share Trend
Figure 37. Global Remdesivir (COVID-19) Sales and Growth Rate (2015-2020) (K Units)
Figure 38. Global Remdesivir (COVID-19) Revenue and Growth Rate (2015-2020) (USD Million)
Figure 39. Global Remdesivir (COVID-19) Revenue Market Share by Regions (2015-2020)
Figure 40. Global Remdesivir (COVID-19) Revenue Market Share by Regions in 2018
Figure 41. North America Remdesivir (COVID-19) Sales and Growth Rate (2015-2020)
Figure 42. Europe Remdesivir (COVID-19) Sales and Growth Rate (2015-2020)
Figure 43. Asia-Pacific Remdesivir (COVID-19) Sales and Growth Rate (2015-2020)
Figure 44. South America Remdesivir (COVID-19) Sales and Growth Rate (2015-2020)
Figure 45. Middle East & Africa Remdesivir (COVID-19) Sales and Growth Rate (2015-2020)
Figure 46. North America Remdesivir (COVID-19) Revenue and Growth Rate (2015-2020) (USD Million)
Figure 47. North America Remdesivir (COVID-19) Sales Market Share by Countries (2015-2020)
Figure 48. North America Remdesivir (COVID-19) Sales Market Share by Countries in 2018
Figure 49. North America Remdesivir (COVID-19) Revenue Market Share by Countries (2015-2020) (USD Million)
Figure 50. North America Remdesivir (COVID-19) Revenue Market Share by Countries in 2018
Figure 51. United States Remdesivir (COVID-19) Sales and Growth Rate (2015-2020) (K Units)
Figure 52. Canada Remdesivir (COVID-19) Sales and Growth Rate (2015-2020) (K Units)
Figure 53. Mexico Remdesivir (COVID-19) Sales and Growth Rate (2015-2020) (K Units)
Figure 54. Europe Remdesivir (COVID-19) Revenue and Growth Rate (2015-2020) (USD Million)
Figure 55. Europe Remdesivir (COVID-19) Revenue Market Share by Countries (2015-2020)
Figure 56. Europe Remdesivir (COVID-19) Revenue Market Share by Countries in 2019
Figure 57. Germany Remdesivir (COVID-19) Sales and Growth Rate (2015-2020) (K Units)
Figure 58. UK Remdesivir (COVID-19) Sales and Growth Rate (2015-2020) (K Units)
Figure 59. France Remdesivir (COVID-19) Sales and Growth Rate (2015-2020) (K Units)
Figure 60. Russia Remdesivir (COVID-19) Sales and Growth Rate (2015-2020) (K Units)
Figure 61. Italy Remdesivir (COVID-19) Sales and Growth Rate (2015-2020) (K Units)
Figure 62. Asia-Pacific Remdesivir (COVID-19) Revenue and Growth Rate (2015-2020) (USD Million)
Figure 63. Asia-Pacific Remdesivir (COVID-19) Sales Market Share by Regions 2019
Figure 64. Asia-Pacific Remdesivir (COVID-19) Revenue Market Share by Regions 2019
Figure 65. China Remdesivir (COVID-19) Sales and Growth Rate (2015-2020) (K Units)
Figure 66. Japan Remdesivir (COVID-19) Sales and Growth Rate (2015-2020) (K Units)
Figure 67. Korea Remdesivir (COVID-19) Sales and Growth Rate (2015-2020) (K Units)
Figure 68. India Remdesivir (COVID-19) Sales and Growth Rate (2015-2020) (K Units)
Figure 69. Southeast Asia Remdesivir (COVID-19) Sales and Growth Rate (2015-2020) (K Units)
Figure 70. South America Remdesivir (COVID-19) Revenue and Growth Rate (2015-2020) (USD Million)
Figure 71. South America Remdesivir (COVID-19) Sales Market Share by Countries in 2019
Figure 72. South America Remdesivir (COVID-19) Revenue Market Share by Countries in 2019
Figure 73. Brazil Remdesivir (COVID-19) Sales and Growth Rate (2015-2020) (K Units)
Figure 74. Argentina Remdesivir (COVID-19) Sales and Growth Rate (2015-2020) (K Units)
Figure 75. Middle East and Africa Remdesivir (COVID-19) Revenue and Growth Rate (2015-2020) (USD Million)
Figure 76. Middle East and Africa Remdesivir (COVID-19) Sales Market Share by Countries in 2019
Figure 77. Middle East and Africa Remdesivir (COVID-19) Revenue Market Share by Countries (2015-2020)
Figure 78. Middle East and Africa Remdesivir (COVID-19) Revenue Market Share by Countries in 2019
Figure 79. Saudi Arabia Remdesivir (COVID-19) Sales and Growth Rate (2015-2020) (K Units)
Figure 80. Egypt Remdesivir (COVID-19) Sales and Growth Rate (2015-2020) (K Units)
Figure 81. Turkey Remdesivir (COVID-19) Sales and Growth Rate (2015-2020) (K Units)
Figure 82. South Africa Remdesivir (COVID-19) Sales and Growth Rate (2015-2020) (K Units)
Figure 83. Global Remdesivir (COVID-19) Sales and Growth Rate (2021-2025) (K Units)
Figure 84. Global Remdesivir (COVID-19) Revenue and Growth Rate (2021-2025) (USD Million)
Figure 85. North America Sales Remdesivir (COVID-19) Market Forecast (2021-2025) (K Units)
Figure 86. Europe Sales Remdesivir (COVID-19) Market Forecast (2021-2025) (K Units)
Figure 87. Asia-Pacific Sales Remdesivir (COVID-19) Market Forecast (2021-2025) (K Units)
Figure 88. South America Sales Remdesivir (COVID-19) Market Forecast (2021-2025) (K Units)
Figure 89. Middle East & Africa Sales Remdesivir (COVID-19) Market Forecast (2021-2025) (K Units)
Figure 90. Sales Channel: Direct Channel vs Indirect Channel
新型コロナウイルス感染症薬物APIの世界市場2020年：企業別、地域別、種類・用途別 Market Overview The COVID-19 Drug API market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, tra…- アルビドール錠（新型コロナウイルス）の世界市場2020年：メーカー別、地域別、種類・用途別 Market Overview The Arbidol Tablets(COVID-19) market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimizat…
- 新型コロナウイルス感染症用クロロキン薬剤の世界市場2020年：メーカー別、地域別、種類・用途別 Market Overview The Chloroquine Drug for COVID-19 market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optim…
- 皮膚科用OTC薬の世界市場2020年：企業別、地域別、種類・用途別 Market Overview The Dermatology OTC Drug market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, …
- 空気式人工呼吸器（新型コロナ）の世界市場2020年：メーカー別、地域別、種類・用途別 Market Overview The Pneumatic Ventilators(COVID-19) market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain opt…